Patents by Inventor Shihuan Kuang

Shihuan Kuang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230277549
    Abstract: Provided is the use of Notch signaling inhibitors such as ?-secretase inhibitors (GSIs), which increase expression of uncoupling protein-1 (UCP-1), to selectively increase browning of white adipose tissue, for example, in the treatment of obesity and metabolic disorders such as type 2 diabetes mellitus (T2DM), fatty liver disease, atherosclerosis, and others, including comorbidities thereof.
    Type: Application
    Filed: July 23, 2021
    Publication date: September 7, 2023
    Applicant: Purdue Research Foundation
    Inventors: Meng Deng, Di Huang, Shihuan Kuang
  • Publication number: 20210393854
    Abstract: Volumetric muscle loss (VML) injuries characterized by critical loss of skeletal muscle tissues result in severe functional impairment. Current treatments involving use of muscle grafts are limited by tissue availability and donor site morbidity. The present application relates to methods and composition matters for skeletal muscle healing and regeneration for a patient with volumetric muscle loss using a glycosaminoglycan-based hydrogel, wherein said hydrogel for skeletal muscle regeneration comprises functionalized hyaluronic acid (HA), functionalized chondroitin sulfate (CS) and poly(ethylene glycol) diacrylate (PEGDA), wherein said HA and said CS are cross-linked by said PEGDA.
    Type: Application
    Filed: April 19, 2021
    Publication date: December 23, 2021
    Applicant: Purdue Research Foundation
    Inventors: MENG DENG, Shihuan Kuang, Naagarajan Narayanan, Liangju Kuang
  • Publication number: 20210330870
    Abstract: A composition for regeneration of skeletal muscle includes a nerve cell secretome or an isolate thereof. An implantable therapeutic material for regeneration of skeletal muscle includes a hydrogel and nerve cells encapsulated within the hydrogel, wherein at least some of the nerve cells are living. A method of regenerating skeletal muscle includes applying the composition or implanting the implantable material adjacent to skeletal muscle myoblasts and/or myogenic cells to regenerate skeletal muscle therefrom.
    Type: Application
    Filed: February 24, 2021
    Publication date: October 28, 2021
    Inventors: Meng Deng, Naagarajan Narayanan, Shihuan Kuang
  • Publication number: 20180326080
    Abstract: This disclosure features the methods and compositions involving development of novel polymer-based therapeutics that induce browning of white adipocytes for the treatment of obesity and its associated metabolic diseases. The therapeutic effects are largely attributed to the promotion of brown and/or beige adipocyte development and function by leveraging adipocyte plasticity and polymer-based drug delivery systems. Both brown and beige adipocytes are densely packed with mitochondria which highly express uncoupling protein-1 (UCP1), a thermogenic protein mediating non-shivering thermogenesis.
    Type: Application
    Filed: October 27, 2016
    Publication date: November 15, 2018
    Applicant: Purdue Research Foundation
    Inventors: Meng Deng, Chunhui Jiang, Liangju Kuang, Shihuan Kuang
  • Publication number: 20150125427
    Abstract: The present invention provides novel stem cells, nucleotide sequences and proteins therefrom. More specifically, the present invention provides Pax7+/Myf5? stem cells and methods for identifying and isolating them. Also provided is a MEGF10 nucleotide sequence and protein.
    Type: Application
    Filed: February 14, 2014
    Publication date: May 7, 2015
    Applicant: Ottawa Health Research Institute
    Inventors: Michael A. Rudnicki, Shihuan Kuang, Chet Holterman
  • Patent number: 8679833
    Abstract: The present invention provides novel stem cells, nucleotide sequences and proteins therefrom. More specifically, the present invention provides Pax7+/Myf5? stem cells and methods for identifying and isolating them. Also provided is a MEGF10 nucleotide sequence and protein.
    Type: Grant
    Filed: January 13, 2012
    Date of Patent: March 25, 2014
    Assignee: Ottawa Health Research Institute
    Inventors: Michael A. Rudnicki, Shihuan Kuang, Chet Holterman
  • Publication number: 20120213751
    Abstract: The present invention provides novel stem cells, nucleotide sequences and proteins therefrom. More specifically, the present invention provides Pax7+/Myf5? stem cells and methods for identifying and isolating them. Also provided is a MEGF10 nucleotide sequence and protein.
    Type: Application
    Filed: January 13, 2012
    Publication date: August 23, 2012
    Applicant: OTTAWA HEALTH RESEARCH INSTITUTE
    Inventors: Michael A. Rudnicki, Shihuan Kuang, Chet Holterman
  • Patent number: 8101407
    Abstract: The present invention provides novel stem cells, nucleotide sequences and proteins therefrom. More specifically, the present invention provides Pax7+/Myf5? stem cells and methods for identifying and isolating them. Also provided is a MEGF10 nucleotide sequence and protein.
    Type: Grant
    Filed: November 22, 2006
    Date of Patent: January 24, 2012
    Assignee: Ottawa Health Research Institute
    Inventors: Michael A. Rudnicki, Shihuan Kuang, Chet Holterman
  • Publication number: 20090074730
    Abstract: The present invention provides novel stem cells, nucleotide sequences and proteins therefrom. More specifically, the present invention provides Pax7+/Myf5? stem cells and methods for identifying and isolating them. Also provided is a MEGF10 nucleotide sequence and protein.
    Type: Application
    Filed: November 22, 2006
    Publication date: March 19, 2009
    Applicant: OTTAWA HEALTH RESEARCH INSTITUTE
    Inventors: Michael A. Rudnicki, Shihuan Kuang, Chet Holterman